Publication:


abstract

This study was conducted to determine the prevalence of hypomagnesemia and its effect on the Lipid profile of local Type II Diabetic Patients. For this purpose, 219 diabetic patients and 100 age-matched control subjects were enrolled. Blood samples of the subjects were analyzed for fasting glucose, Mg, triglyceride, total cholesterol, HDL-cholesterol, and LDL-cholesterol. Results showed that mean Serum values of these parameters were differing in diabetic patients as compared to control subjects. The reference range of serum Magnesium in healthy controls was 1.2-4.4 mg/dl. Mean serum magnesium in diabetic patients was significantly lower as compared to healthy subjects (1.6 ± 0.23 mg/dl vs. 2.8 ±0.8 mg/dl). Among diabetic patients, 143 (65.3%) had serum magnesium level below 1.7 mg/dl (hypomagnesemia). The corresponding figure for control subjects was 11 (11%). The difference was significant (p < 0.01). Diabetes mellitus patients with current hyperglycemic status had significantly lower serum Mg as compared to euglycemic patients (p = 0.05). Serum Mg in diabetic patients was correlated with all lipid parameters. Among them, HDL-cholesterol was significantly (p < 0.05) positively correlated (r = 0.34), while total cholesterol and LDL-cholesterol was negatively correlated, albeit non-significantly, with serum Mg. These results demonstrate that hypomagnesemia is accompanied by Atherogenic alterations in the lipid profiles of type II diabetic patients of Lahore, Pakistan.

Related Articles
Effect of oral magnesium supplementation on the lipid profile and blood glucose of patients with type 2 diabetes mellitus.
J Assoc Physicians India. 2003
Effect of oral magnesium supplementation on the lipid profile and blood glucose of patients with type 2 diabetes mellitus.
Lal J, Vasudev K, Kela AK, Jain SK. J Assoc Physicians India. 2003 Jan; 51:37-42.
Hypomagnesemia is linked to low serum HDL-cholesterol irrespective of serum glucose values.
J Diabetes Complications. 2000
Hypomagnesemia is linked to low serum HDL-cholesterol irrespective of serum glucose values.
Guerrero-Romero F, Rodríguez-Morán M. J Diabetes Complications. 2000 Sep-Oct; 14(5):272-6.
Clinical characteristics of type II diabetic subjects consuming high versus low carbohydrate diets in Mexico City and San Antonio, Texas.
Diabetes Care. 1994
Clinical characteristics of type II diabetic subjects consuming high versus low carbohydrate diets in Mexico City and San Antonio, Texas.
Gonzélez C, Stern MP, Mitchell BD, Valdez RA, Haffner SM, Pérez BA. Diabetes Care. 1994 May; 17(5):397-404.
Decreased serum magnesium and zinc levels: atherogenic implications in type-2 diabetes mellitus in Nigerians.
Nutr Health. 2002
Decreased serum magnesium and zinc levels: atherogenic implications in type-2 diabetes mellitus in Nigerians.
Anetor JI, Senjobi A, Ajose OA, Agbedana EO. Nutr Health. 2002; 16(4):291-300.
Review Beyond low-density lipoprotein: addressing the atherogenic lipid triad in type 2 diabetes mellitus and the metabolic syndrome.
Am J Cardiovasc Drugs. 2005
Review Beyond low-density lipoprotein: addressing the atherogenic lipid triad in type 2 diabetes mellitus and the metabolic syndrome.
Nesto RW. Am J Cardiovasc Drugs. 2005; 5(6):379-87.